logo
  • Nonprofit News
  • Management
    • Boards and Governance
    • Communication
      • Framing & Narratives
    • Ethics
    • Financial Management
    • Fund Development
    • Leadership
    • Technology
  • Philanthropy
    • Corporate Social Responsibility
    • Donor-Advised Funds
    • Foundations
    • Impact Investing
    • Research
    • Workplace Giving
  • Policy
    • Education
    • Healthcare
    • Housing
    • Government
    • Taxes
  • Economic Justice
    • Economy Remix
    • Economy Webinars
    • Community Benefits
    • Economic Democracy
    • Environmental Justice
    • Fair Finance
    • Housing Rights
    • Land Justice
    • Poor People’s Rights
    • Tax Fairness
  • Racial Equity
  • Social Movements
    • Community Development
    • Community Organizing
    • Culture Change
    • Education
    • Environment
    • Gender Equality
    • Immigrant Rights
    • Indigenous Rights
    • Labor
    • LGBTQ+
    • Racial Justice
    • Youth Activism
  • About Us
  • Log in
  • CONTENT TYPES
  • Webinars
    • Leading Edge Membership
    • Sponsored Webinars
    • Economic Justice
  • Tiny Spark Podcast
  • Magazine
    • Magazine
    • Leading Edge Membership
Donate
Board Ethics and Conflicts of Interest, Transparency

When Nonprofits and For-Profits Get Cozy: Sloan Kettering’s Identity Problem

Martin Levine
January 3, 2019
Share9
Tweet8
Share
Email
17 Shares

December 31, 2018; New York Times

Difficult, persistent social problems are not in short supply. When existing responses fall short, we hunger for new, more effective approaches. For nonprofits, the challenge is often to find resources to support innovation and, when successful, bring it to scale so the benefits can be widely shared.

But the recent struggles of the Memorial Sloan Kettering Cancer Center (MSKCC) illustrate that as rewards increase, so do ethical challenges. Protecting a nonprofit’s autonomy is a challenge. While the costs and potential profits of medical research are larger than those facing many nonprofits, the need for ethical clarity is the same.

Medical research is expensive. New treatments may improve the lives of millions and, if developed commercially, become very profitable. For MSKCC, pursuing potential gains while remaining true to its mission has been challenging. Brad Loncar, founder of an investment fund that invests in medical research, recently told the New York Times that “Closer ties between nonprofit research centers like MSKCC and corporations are being fueled by a rush of potentially breakthrough cancer treatments. Venture capital firms and drug companies have looked to cash in on the scientific discoveries. Money follows success.”

Increasingly, MSKCC has become more comfortable with forming close and intertwined relationships with for-profit organizations, even at the potential cost of compromising its autonomy. Dr. Lisa DeAngelis, MSKCC’s medical director, told the Times that while “someone might think that business relationships are problematic…I’m telling you, as someone who works with patients, and I’ve worked with patients throughout my entire career here, that working with industry has helped me save lives.”

Researchers have been allowed to form close relationships with commercial partners, even becoming co-owners of new businesses that profit off of innovations created by the nonprofit cancer center: “In recent years, the hospital, like its competitors, has struck increasingly sophisticated deals to commercialize its discoveries, in some cases receiving equity stakes in start-ups rather than simply collecting royalties.”

For some, the benefits of these ties are outweighed by the risks:

Ethicists and health experts say having leaders and researchers at nonprofit hospitals sit on corporate boards is especially problematic. When they serve on the board of a publicly traded company, they have a legal duty to the corporation and its shareholders, which can clash with their duty to their patients and primary employers. Those who sit on boards are often paid hundreds of thousands of dollars a year…

The whole reason for being in the cancer care business is that you’re trying to help people in need, and that’s not at all the company’s main purpose. It’s to generate profits on their products.

In a letter to its medical staff, MSKCC’s leadership saw only an issue of transparency.

There is clearly a field-wide debate occurring right now over transparency and the opaque rules that guide disclosure in medical journals. Researchers, journals, and nonprofit research institutions are engaged in serious discussions on solving this problem…

We have been conducting a full review of disclosure policies to ensure that we are advancing cancer research in the most ethical and transparent way possible…

We want to be abundantly clear that [MSKCC] stands firm behind our colleagues and our commitment to work with industry and to responsibly develop new scientific discoveries for the benefit of cancer patients. Our faculty are committed to personal integrity and professional ethics, with the singular focus of our mission. Central to that mission is our focus on taking basic science and developing it into lifesaving therapeutics to fight cancer—an accomplishment that can rarely happen in academia alone.

The growing role of for-profit organizations in areas previously not seen as of commercial interest makes MSKCC’s experience of wider interest for the field. As funders see profit potential in the work of nonprofits, how will leaders protect their autonomy, their mission, and the interests of those they serve? Hopefully, these questions can be asked and answered before new relationships are formed and too much damage is done.—Martin Levine

Share9
Tweet8
Share
Email
17 Shares

About The Author
Martin Levine

Martin Levine is a Principal at Levine Partners LLP, a consulting group focusing on organizational change and improvement, realigning service system to allow them to be more responsive and effective.Prior to forming Levine Partners, Mr. Levine served the CEO of JCC Chicago creating a purpose driven organization, continuously realigning service and management systems to responsively and effectively fulfill JCC Chicago’s mission.Over the past 35 years Mr. Levine made major contributions to the transformation of JCC Chicago to its present position as a pre-eminent JCC in North America. Mr. Levine focused on strengthening the JCC’s effectiveness as a Jewish Community Building and Jewish Educational organization dedicated to “Bringing Jewish Values to Life” in all aspects of JCC programs and services.Mr. Levine was been responsible for the development of new facilities as part of JCC Chicago’s response to the changing demography of the Metropolitan Jewish Community. In addition, Mr. Levine had responsibility for guiding the Chicago JCC’s integration of its service and business strategies into a holistic approach.In addition to his JCC responsibilities, Mr. Levine served as a consultant on organizational change and improvement to school districts and community organizations.Mr. Levine has published several articles on change and has presented at numerous conferences on this subject.Mr. Levine held membership in many professional organizations including the Association of Jewish Center Professionals (Board member), Association for the Advancement of Social Work with Groups, Association for Quality and Participation, and the Future Search Alliance.A native of New York City, Mr. Levine is a graduate of City College of New York (BS in Biology) and Columbia University (MSW). He has trained with the Future Search and the Deming Institute.Mr. Levine served as President of the Gan Project, an organization committed to engaging communities in locally and ethically produced food.

Related
Racial Disparities in Pain Prescriptions Kept Thousands of Black Patients Alive
By Steve Dubb
November 26, 2019
Jewish Nonprofit Employees Decide They Too Want Radical Salary Transparency
By Steve Dubb
November 21, 2019
This Board’s Problem Is Not Odd—It’s Even
By Steve Dubb
November 18, 2019
The Big Rebrand: A YMCA Tries On an Alternative Identity
By Martin Levine
October 30, 2019
Long Arm of Big Pharma Buys Sheriffs’ Nonprofit Cheap
By Ruth McCambridge
October 24, 2019
Open Source Research Center on Alzheimer’s: It Takes a Nonprofit
By Erin Rubin
October 3, 2019
other posts by The Author
ALEC Stays True to Its Roots…and That’s Scary
By Martin Levine
December 10, 2019
Has Yale Just Been Bought Off?
By Martin Levine
December 9, 2019
School Segregation? Not a Problem, Says DeVos
By Martin Levine
December 6, 2019
A Series on Sensemaking Organizations
The Sensemaking Organization: Designing for Complexity
The Sensemaking Mindset: Improvisation over Strategy
Structuring for Sensemaking: The Power of Small Segments
logo
Donate
  • About
  • Contact
  • Newsletters
  • Write for NPQ
  • Advertise
  • Writers
  • Funders
  • Copyright Policy
  • Privacy Policy

Subscribe to View Webinars

We are using cookies to give you the best experience on our website.

 

Non Profit News | Nonprofit Quarterly
Powered by GDPR plugin
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.